Indivior CAO buys 1,500 shares at $35.69

Indivior Pharmaceuticals, Inc. (INDV) reported that Chief Accounting Officer Anderson Woodrow D purchased 1,500 shares of its Common Stock on August 27, 2026 in an open market or private transaction at a price of $35.69 per share.

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. (INDV) reported that Chief Accounting Officer Anderson Woodrow D purchased 1,500 shares of its Common Stock on August 27, 2026 in an open market or private transaction at a price of $35.69 per share. Following this transaction, he directly owns 27,638 shares of Indivior common stock.

Insider Trade Summary

Net Buyer: 1,500 shares

Net Buy 1 txn

Insider Anderson Woodrow D

Role Chief Accounting Officer

Bought 1,500 shs ($54K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,500	$35.69	$54K

Holdings After Transaction: Common Stock — 27,638 shares (Direct)

Key Figures

Shares purchased: 1,500 shares of Common Stock Purchase price per share: $35.69 per share Shares owned after transaction: 27,638 shares

3 metrics

Shares purchased 1,500 shares of Common Stock Open market or private purchase on August 27, 2026

Purchase price per share $35.69 per share Price for the 1,500-share purchase on August 27, 2026

Shares owned after transaction 27,638 shares Direct ownership by Anderson Woodrow D after the reported purchase

Key Terms

Form 4, Common Stock, Rule 10b5-1, open market or private transaction

4 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 regulatory

"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"transaction_code_description: "Purchase in open market or private transaction""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INDV report for Anderson Woodrow D?

Indivior Pharmaceuticals, Inc. reported that Chief Accounting Officer Anderson Woodrow D purchased 1,500 shares of its Common Stock on August 27, 2026 in an open market or private transaction at $35.69 per share.

How many INDV shares does Anderson Woodrow D own after this Form 4 transaction?

After the reported purchase, Anderson Woodrow D directly owns 27,638 shares of Indivior Pharmaceuticals, Inc. Common Stock, as shown in the Form 4 filing’s post-transaction holdings field.

At what price were the INDV shares bought in this Form 4 filing?

The 1,500 shares of Indivior Pharmaceuticals, Inc. (INDV) Common Stock were purchased at a price of $35.69 per share, as indicated in the Form 4 transaction price field with per-share semantics.

Was the INDV insider trade made under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is marked false, indicating the filing states the transaction was not affirmed as made pursuant to a Rule 10b5-1 trading plan.

What is the transaction code used in the INDV Form 4 for this trade?

The trade is reported with transaction code P, which the Form 4 description identifies as a “Purchase in open market or private transaction.” This corresponds to a buy of 1,500 shares of Indivior Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 04:01 PM EDT Accepted by SEC EDGAR 08/27/2026 - 04:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson Woodrow D

(Last) (First) (Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD VIRGINIA 23235

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2026		P		1,500	A	$35.69	27,638	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/Alice Givens, Power of Attorney	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)